EVH — Evolent Health, Inc.
—
NYSE ·
Unknown ·
Unknown ·
CIK 1628908 ·
Last close
$4.62
Market Cap
$522.55M
52W High
$6.26
52W Low
$2.10
ADV30
1,847,263
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 725,367,000 | 88,421,000 | -6,188,000 | -23,566,000 | 1,962,156,000 | 148,255,000 | 1,589,306,000 |
| Jun 2026 | 652,520,000 | 80,836,000 | -9,561,000 | -28,364,000 | 1,971,894,000 | 115,703,000 | 1,588,671,000 |
| Mar 2026 | 496,246,000 | 83,774,000 | -10,599,000 | -26,632,000 | 1,878,847,000 | 142,028,000 | 1,482,454,000 |
| Dec 2025 | 468,719,000 | 97,253,000 | -20,440,000 | -429,131,000 | 1,899,236,000 | 151,856,000 | 1,484,042,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$64,882,000
Investing CF
$-29,323,000
Financing CF
$-112,553,000
CapEx
$-28,225,000
Dividends Paid
$0
Buybacks
$0
EPS Diluted TTM
$-4.54
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,393,889,000
Inventory
—
Receivables
$442,766,000
ST Investments
—
EBIT TTM
$-436,127,000
Pretax Income TTM
$-504,627,000
Interest Exp TTM
$68,500,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,342,852,096
EBITDA
$56,017,000
Free Cash Flow
$142,848,128
Enterprise Value
$1,342,818,304
Total Cash
$148,255,008
Total Debt
$973,049,984
Shares Out
113,105,519
Trailing EPS
$-4.46
Book Value
$3.30
ROE
-83.6%
ROA
-0.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,876,229,000 | -19,834,000 | -534,510,000 | 1,899,236,000 | 1,484,042,000 | 415,194,000 | 38,843,000 |
| Dec 2024 | 2,554,741,000 | -14,067,000 | -61,623,000 | 2,544,411,000 | 1,543,152,000 | 1,001,259,000 | 18,765,000 |
| Dec 2023 | 1,963,896,000 | -21,055,000 | -113,040,000 | 2,680,308,000 | 1,612,607,000 | 1,067,701,000 | 142,582,000 |
| Dec 2022 | 1,352,013,000 | -19,880,000 | -19,164,000 | 1,817,293,000 | 957,876,000 | 859,417,000 | -11,553,000 |
TTM Snapshot
Revenues TTM
$2,097,018,000
NetIncome TTM
$-504,991,000
OpCashFlow TTM
—
Assets (Latest)
$1,971,894,000
Forward EPS
$0.40
Max Pain — expiry 2027-01-15
max pain strike: $2.50 · spot: $3.93 · call oi: 6,002 · put oi: 1,395
Expected Move to 2027-01-15:
±$1.43
(36.26%) —
implied range
$2.51 –
$5.36
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FAX | ABRDN ASIA-PACIFIC INCOME FUND, INC. | $521.81M | $12.64 | — |
| NDMO | Nuveen Dynamic Municipal Opportunities Fund | $526.82M | $8.71 | — |
| EBF | ENNIS, INC. | $528.38M | $20.87 | — |
| EMD | WESTERN ASSET EMERGING MARKETS DEBT FUND INC. | $529.57M | $9.11 | — |
| AFYA | Afya Ltd | $514.01M | $10.30 | — |
News headlines (Yahoo Finance, 1h cache)
EVH Q3 2026 deep dive: ongoing AI investment and customer expansion shape outlook
2026-11-09 13:01 · Yahoo
What Evolent Health (EVH) Said on Its Q3 Earnings Call
2026-11-07 09:17 · Yahoo
Evolent Health, Inc. Q3 2026 Earnings Call Summary
2026-11-05 23:49 · Yahoo
Evolent Health (EVH) Q3 2026 Earnings Call Transcript
2026-11-05 19:16 · Yahoo
Evolent Health (EVH) Matches Q3 Earnings Estimates
2026-11-05 13:35 · Yahoo
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics
2026-11-05 13:30 · Yahoo
Evolent Health: Q3 Earnings Snapshot
2026-11-05 12:20 · Yahoo
Evolent Announces Third Quarter 2026 Results
2026-11-05 12:00 · Yahoo
3 Value Stocks with Warning Signs
2026-10-22 20:53 · Yahoo
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds
2026-10-13 12:27 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.